News
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes ...
The Food and Drug Administration (FDA) announced plans to significantly curtail people’s access to Covid-19 vaccines.
Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.
As the Trump administration’s FDA moves to limit approval for COVID-19 booster shots, millions of Americans under 65 may find ...
4h
India Today on MSNCovid-19 vaccine rules may change from 2025: What you should knowThe FDA may limit annual COVID-19 boosters to high-risk groups unless clinical trials prove benefits for healthy adults under ...
The FDA’s recent activities regarding Covid-19 vaccines stray far from the well-established standards of vaccine regulatory ...
Government vaccine advisers are meeting to decide if the recipe for COVID-19 vaccines needs updating for this fall and winter ...
The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...
Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...
"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA ...
Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results